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It is my pleasure to tell you about all that has happened to the Asia-Pacific Journal of Clinical Oncology (APJON) journal in just 2 years. It has been quite a remarkable history! APJON is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia-Pacific region in relation to cancer treatment and care. The main audience is cancer nurses. We chose to become a free open access journal meaning anyone at any time can go to our web site (<http://www.apjon.org>) to read and copy any portion of the journals published to date. We are also the official journal of the Asian Oncology Nursing Society (AONS). They have a page in every journal for posting AONS news.

We have been delighted by APJON's growth, visibility, and rate of development. This is an international journal with a focus on Asia-Pacific region. It is reflected in the contributions of authors that have come from many parts of the world including Australia, Oman, Canada, Finland, Spain, Japan, Nigeria, the United States of America, and the United Kingdom \[[Figure 1](#F1){ref-type="fig"}\]. This wide international spread of authors is one unique characteristic of the journal. Another is the special topic that is featured in each issue with an appointed special editor. Examples of the selected topics are information needs in cancer care and prevention and another that is on complementary and alternative medicine in cancer care.
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At the time of writing, we have published 91 articles which include completed systematic reviews, methods papers, and other types of articles \[[Figure 2](#F2){ref-type="fig"}\]. Topics cover a wide spectrum of health issues, relating to cancer care such as clinical articles such as Familiarity, Opinions, Experiences, and Knowledge about Scalp Cooling: A Dutch Survey among Breast Cancer Patients and Oncological Professionals;\[[@ref1]\] research articles such as Factors in the Prioritization of Information Needs among Hong Kong Chinese Breast Cancer Patients;\[[@ref2]\] and educational articles such as: Oncology Nurse Prescribing: A Catalonian Survey.\[[@ref3]\] Some articles have been highly accessed, meaning that within a short period of time of being published they have been retrieved by readers.
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Based on data from the journal's website, it is gaining momentum and attracting interest from readers. When we launched the journal, we had about 1,000 visits per month which have grown more than 3,000 to more than 5,000 visits per month \[[Figure 3](#F3){ref-type="fig"}\]. We are very gratified with our early progress and thank all of our authors who took a risk and submitted their research to the journal.
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If you have an idea for a topic, you would like to see explored by authors across the globe send it to us electronically. If selected the staff will help you find authors to write their perspective on the topic.

In 2016-17, we will be implementing a number of interesting strategies.

Readers can look forward to reading the special topic that will appear in each journal in 2016 and 2017. To date, plans have been made to explore the following topics:
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Global Health Disparities Focus on Cancer

Guest editor: Haeok Lee, RN, Ph.D., FAAN, USA
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Retinoblastoma

Guest editor: Mary Elizabeth Davis, RN, MSN, AOCN, USA
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Cancer Nursing in Africa

Guest editor: David Makumi, RN, MS, Kenya
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Oral Agents in Cancer Treatment

Guest editor: Sultan Kav, Ph.D., RN, Turkey
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The Role of the Nurse Specialist in Various Areas of Oncology

Guest editor: Ilana Kadmon, Ph.D., RN, Israel

APJON is indexed in Emerging Sources Citation Index, which is a new edition of the Web of Science that launched in November 2015. This means that any articles published in the journal will be indexed in the Web of Science at the time of publication. We are waiting for the result from the PubMed, and we will be applying for Medline in 2017.

In closing, I want to thank our editorial staff from China, for all the time and work they have done this past 2 years, our publisher Wolters Kluwer - Medknow who makes our journal looks professional. We have many volunteers that given their time and expertise: The forty volunteer contributing editors who have committed to reading manuscripts within a month of receiving them thus guarantee a fast turnaround for authors, associate editors Winnie So for research, Sultan Kav for education, and Myungsun Yi for clinical and biostatistics consultants, Doris Leung and Kai Chow Choi (see inside cover of the journal to see the listing). It is obvious to me that it takes a large number of dedicated people to start a new journal. I am so appreciative of those who willingly took up the challenge to work hand in hand with our editorial staff and myself to make this journal a reality. Happy Birthday APJON!

We hope authors will consider the journal to disseminate their research educational innovations and clinical guidelines and unique practices. We remain committed to innovation and to open access, including helping to ensure the widest possible readership for all articles published in the journal.
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